Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,789 public trials 1,783 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Active, not recruiting

Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer

NCT03941730

Conditions
Advanced Triple-Negative Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, +9 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • UCSF Medical Center-Mission Bay San Francisco, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
View Trial Details
Active, not recruiting

Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)

NCT04152499

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +48 more
Locations
  • Los Angeles Hematology Oncology Medical Group Glendale, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Florida Cancer Specialists and Research Institute Sarasota, Florida, United States
  • START MidWest Grand Rapids, Michigan, United States
View all 109 locations
View Trial Details
Active, not recruiting

A Study of T-DXd as Monotherapy or in Combination With Anti-cancer Agents in Patients With Selected HER2-expressing Tumors

NCT06271837

Conditions
Advanced Solid Tumors (Excluding Gastric Cancer and Breast Cancer), Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Research Site Beijing, China
  • Research Site Beijing, China
  • Research Site Changchun, China
  • Research Site Changsha, China
View all 29 locations
View Trial Details
Active, not recruiting

Adj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBC

NCT04055493

Conditions
Breast Cancer Female, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Ost-Alb Klinikum Brustzentrum Aalen, Baden-Wurttemberg, Germany
  • Stadtklinik Baden-Baden Brustzentrum Baden-Baden, Baden-Wurttemberg, Germany
  • Kreiskliniken Böblingen Klinikum Böblingen Frauenklinik Böblingen, Baden-Wurttemberg, Germany
  • Uniklinikum Freiburg Frauenklinik Freiburg im Breisgau, Baden-Wurttemberg, Germany
View all 86 locations
View Trial Details
Active, not recruiting

T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases

NCT06048718

Conditions
Brain Diseases, Brain Neoplasms, Breast Cancer, +11 more
Locations
  • Salzburg Cancer research Institute-Center Salzburg, Austria
  • Medical University of Vienna Vienna, Austria
  • Hospital Universitario San Juan de Alicante Alicante, Spain
  • Hospital Universitari Dexeus Barcelona, Spain
View all 13 locations
View Trial Details

Related conditions